FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
13/06/2025
Voltar para busca
Dado oficial do USPTO
RIGENASIDE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
RIGENASIDE
ST13
US500000079373811Classe
3, 5, 10
Pedido
79373811
Registro
7602060
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
42
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
3, 5, 10
Data de depósito
05/04/2023
Data de registro
17/12/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
17/12/2024
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
IT
Examinador
GOODWIN, KATRINA JOYE
Unidade examinadora
L50
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
FARMACEUTICI DAMOR S.P.A.
Representantes
Ben Natter HAUG PARTNERS, LLP
Classificação técnica
Classes Nice
Classe 3Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Cosmetic creams; cosmetic barrier creams; skin care preparationsother than for medical purposes; non-medicated creams for stretch marks and cellulite blemishes; cosmetic firming and slimming creams; anti-aging creams; anti-wrinkle creams; creams for skin spotsother than for medical purposes; non-medicated face and body exfoliant creams and moisturizers; massage creams and oils; beauty masks; non-medicated face and body soaps and gels; non-medicated skin care creams; soaps and intimate hygiene preparationsother than for medical purposes; cosmetic preparations for tanning the skin and sunscreen preparations; nail care preparationsother than for medical purposes; nail varnish; body cleaning preparations; deodorants and antiperspirants; make-up preparations and make-up removers; foundation and face make-up; non-medicated hair and bath preparations and treatments; hair removal and shaving preparations; non-medicated sanitary preparations being toiletries; perfumery; fragrances; essential oils and bath oils for use in aroma therapy; non-medicated oral hygiene preparations
Classe 5
Pharmaceutical preparations for the treatment of dermatological diseases and disorders; natural remedies for the treatment of dermatological diseases and disorders in the nature of wheat-based preparations; pharmaceutical products for gynecological usetherapeutic topical creams for the treatment of gynecological diseases and disorders; medical preparations for dermatological use; pharmaceutical creamsmedicated lip creamscreams for dermatological use; medicinal creams for skin care; protective creams for dermatological use; topical analgesic creams; medicated creams and medical preparations for treatment of scarsskin blemishesdermatitis and psoriasis; medicinal creams and medicated preparations for intimate hygiene; dressingsmedical; sterilized dressing; disinfectants and antiseptics; bandages and plasters for skin wounds; cotton for medical purposes; sanitary preparations for medical use; medicinal mud; bath preparations for medical purposes; nutritional supplements and dietary supplements for human use; pre-filled syringes for medical purposessyringes sold filled with pharmaceutical preparations for the treatment of dermatological diseases and conditions; gauze for dressings
Classe 10
Syringes for medical purposes; disposable syringes; syringes for injections; vaginal syringes; hypodermic syringes; applicators for pharmaceutical preparations in the nature of syringes; apparatus for administering intravenous solutions in the nature of syringes; intravenous administration instruments for medical purposes in the nature of syringes; devices for injecting pharmaceuticals in the nature of syringes; apparatus for administering pharmaceuticals in the nature of syringes; medical apparatus and instruments for use in the removal of blemishes in subjects with signs of skin aging; therapeutic facial masks; apparatusdevices and instruments used in aesthetic medicine and dermatology treatments in the nature of medical devices to remove blemishes in subjects with signs of skin aging; apparatusdevices and instruments used in curative cosmetics in the nature of facial toning machines for cosmetic use; medical equipmentdevices and instruments used in cosmetics in the nature of medical devices for nonsurgical cosmetic treatments; injectors for medical purposes; surgical implants comprised of artificial material; esthetic massage apparatus; apparatus for acne treatment
Publicações
Histórico de despachos e eventos da marca no USPTO.
42 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
23/05/2025
FIMP
FINAL DISPOSITION PROCESSED
23/05/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
17/03/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
28/12/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
17/12/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
17/12/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/12/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15/10/2024
PUBO
PUBLISHED FOR OPPOSITION
15/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/09/2024
GPNX
NOTIFICATION PROCESSED BY IB
28/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/07/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
26/07/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
26/07/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
26/07/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
26/07/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
24/07/2024
GPNX
NOTIFICATION PROCESSED BY IB
01/07/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
14/06/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13/06/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/06/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
23/05/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
23/05/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
23/05/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
23/05/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
23/05/2024
GRML
CORRESPONDENCE E-MAILED
23/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/05/2024
RFNT
REFUSAL PROCESSED BY IB
14/02/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
25/01/2024
RFRR
REFUSAL PROCESSED BY MPU
25/01/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/01/2024
CNRT
NON-FINAL ACTION WRITTEN
09/01/2024
DOCK
ASSIGNED TO EXAMINER
02/01/2024
MAFR
APPLICATION FILING RECEIPT MAILED
20/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/07/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/07/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace RIGENASIDE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.